title: Prostate cancer: new types of radiotherapy improve cancer outcome but at what cost?
abstract: New and very expensive forms of radiotherapy, such as intensity-modulated radiation therapy and proton therapy, have taken over the localized prostate cancer market. But is there enough evidence to justify their increased utilization and if so, how can we possibly afford them?
authors: Division of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, VIC 3003, Australia.
authors: Declan G
authors: DG
authors: Murphy
authors: Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC 3003, Australia.
authors: Scott
authors: S
authors: Williams
authors: Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA 94143-1695, USA.
authors: Matthew R
authors: MR
authors: Cooperberg
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D061766:Proton Therapy / Q000191:economics*; D050397:Radiotherapy, Intensity-Modulated / Q000191:economics*